文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛

心源性休克或心脏骤停患者经皮血管造影引导与外科VA-ECLS置入的比较

Percutaneous angio-guided versus surgical veno-arterial ECLS implantation in patients with cardiogenic shock or cardiac arrest.
PubMed 文献 · Resuscitation · 2021-11-23
一句话结论经皮血管造影引导VA-ECLS置入较外科置入大血管并发症更少(11% vs 42%),30天死亡率无显著差异。

本研究纳入本中心2018年3月至2021年3月因难治性心源性休克或心脏骤停行急诊股-股VA-ECLS的患者120例(外科组59例,经皮血管造影引导组61例),比较生存率与主要并发症。结果显示两组30天死亡率无显著差异,但经皮血管造影引导组大血管并发症更少(42% vs 11%,p>0.0001),且VA-ECLS拔管率更高;多因素分析示经皮血管造影引导置入与主要并发症概率更低独立相关。作者认为经皮血管造影引导VA-ECLS置入较外科置入大血管并发症更少,但需更大规模研究确认并评估对死亡率的影响。

要点

  • 经皮血管造影引导VA-ECLS置入组大血管并发症发生率11%,外科组42%(p>0.0001)。
  • 两组30天死亡率无显著差异。
  • 经皮血管造影引导组VA-ECLS拔管率更高。
  • 多因素分析中,经皮血管造影引导置入与主要并发症概率更低独立相关。

适用人群与场景

  • 本中心2018年3月至2021年3月因难治性心源性休克或心脏骤停行急诊外周股-股VA-ECLS置入的患者。

研究设计与关键结果

  • 研究类型:本中心单中心研究;样本量120例;人群:因难治性心源性休克或心脏骤停行急诊外周股-股VA-ECLS置入的患者;干预与对照:经皮血管造影引导置入组61例 vs 外科置入组59例。
  • 两组基线特征与严重程度评分均衡。
  • 30天死亡率两组无显著差异。
  • 经皮血管造影引导组大血管并发症发生率11%,外科组42%(p>0.0001)。
  • 经皮血管造影引导组VA-ECLS拔管率更高。
  • 多因素分析:经皮血管造影引导置入与主要并发症概率更低独立相关。

证据类型、等级与局限

  • 证据类型:本中心研究(作者称需更大规模研究确认结果并评估对死亡率的影响)。
  • 局限:作者指出需更大规模研究确认结果并评估对死亡率的影响。

对床旁实践的改变

  • 对比外科置入,经皮血管造影引导VA-ECLS置入与更少的大血管并发症相关,可减少大血管并发症;但30天死亡率无显著差异。
  • 作者认为需更大规模研究确认上述结果并评估对死亡率的影响。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Veno-arterial Extracorporeal Life Support (V-A ECLS) has gained increasing place into the management of patients with refractory cardiogenic shock or cardiac arrest. Both surgical and percutaneous approach can be used for cannulation, but percutaneous approach has been associated with fewer complications. Angio-guided percutaneous cannulation and decannulation may further decrease the rate of complication. We aimed to compare outcome and complication rates in patients supported with V-A ECLS through percutaneous angio-guided versus surgical approach.

METHODS: We included all patients with emergent peripheral femoro-femoral V-A ECLS implantation for refractory cardiogenic shock or cardiac arrest in our center from March 2018 to March 2021. Survival and major complications (major bleeding, limb ischemia and groin infection) rates were compared between the percutaneous angio-guided and the surgical groups.

RESULTS: One hundred twenty patients received V-A ECLS, 59 through surgical approach and 61 through angio-guided percutaneous approach. Patients' baseline characteristics and severity scores were equally balanced between the 2 groups. Thirty-day mortality was not significantly different between the 2 approaches. However, angio-guided percutaneous cannulation was associated with fewer major vascular complications (42% vs. 11%, p > 0.0001) and a higher rate of V-A ECLS decannulation. In multivariate analysis, percutaneous angio-guided implantation of V-A ECLS was independently associated with a lower probability of major complications.

CONCLUSION: Compared to surgical approach, angio-guided percutaneous V-A ECLS implantation is associated with fewer major vascular complications. Larger studies are needed to confirm those results and address their impact on mortality.

来源:Resuscitation,查看原文。版权归原作者所有。

参考来源

  1. Saiydoun G, Gall E, Boukantar M, et al. Percutaneous angio-guided versus surgical veno-arterial ECLS implantation in patients with cardiogenic shock or cardiac arrest. Resuscitation. 2021. PMID: 34826577. doi:10.1016/j.resuscitation.2021.11.018

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。